
Sign up to save your podcasts
Or


Dr Curigliano and Dr Loi discuss the latest clinical data regarding the use of PARP inhibitors in early high-risk breast cancer.
Credit available for this activity expires: 7/29/2022 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/955496?src=mkm_podcast_addon_955496
By Medscape Podcasts4
77 ratings
Dr Curigliano and Dr Loi discuss the latest clinical data regarding the use of PARP inhibitors in early high-risk breast cancer.
Credit available for this activity expires: 7/29/2022 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/955496?src=mkm_podcast_addon_955496

137 Listeners

320 Listeners

497 Listeners

101 Listeners

885 Listeners

13 Listeners

17 Listeners

287 Listeners

3,341 Listeners

1,153 Listeners

194 Listeners

87 Listeners

513 Listeners

365 Listeners

61 Listeners

25 Listeners

432 Listeners

370 Listeners